National Health Investors Stock Forecast, Price & News

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last twelve months. There are currently 2 sell ratings and 6 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" National Health Investors stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View analyst ratings for National Health Investors or view top-rated stocks.

Wall Street analysts have given National Health Investors a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but National Health Investors wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

National Health Investors is scheduled to release its next quarterly earnings announcement on Monday, May 10th 2021.
View our earnings forecast for National Health Investors.

National Health Investors, Inc. (NYSE:NHI) announced its earnings results on Sunday, February, 21st. The real estate investment trust reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by $0.19. The real estate investment trust had revenue of $81.24 million for the quarter, compared to the consensus estimate of $84.22 million. National Health Investors had a net margin of 56.94% and a trailing twelve-month return on equity of 12.64%. The business's revenue for the quarter was down 1.2% on a year-over-year basis. During the same period in the previous year, the business posted $1.41 earnings per share.
View National Health Investors' earnings history.

National Health Investors' stock was trading at $70.86 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NHI shares have increased by 0.1% and is now trading at $70.91.
View which stocks have been most impacted by COVID-19.

National Health Investors declared a quarterly dividend on Tuesday, December 15th. Shareholders of record on Thursday, December 31st will be paid a dividend of $1.102 per share on Friday, January 29th. This represents a $4.41 annualized dividend and a dividend yield of 6.22%. The ex-dividend date of this dividend is Wednesday, December 30th.
View National Health Investors' dividend history.

National Health Investors pays an annual dividend of $4.41 per share and currently has a dividend yield of 6.50%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. National Health Investors has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of National Health Investors is 80.18%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, National Health Investors will have a dividend payout ratio of 78.05% in the coming year. This indicates that National Health Investors may not be able to sustain their current dividend.
View National Health Investors' dividend history.

8 analysts have issued 1-year price objectives for National Health Investors' shares. Their forecasts range from $40.00 to $68.00. On average, they anticipate National Health Investors' stock price to reach $59.33 in the next twelve months. This suggests that the stock has a possible downside of 16.3%.
View analysts' price targets for National Health Investors or view top-rated stocks among Wall Street analysts.

Some companies that are related to National Health Investors include American Tower (AMT), Public Storage (PSA), Welltower (WELL), Weyerhaeuser (WY), Ventas (VTR), Extra Space Storage (EXR), Medical Properties Trust (MPW), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Life Storage (LSI), Rayonier (RYN), Ryman Hospitality Properties (RHP), Healthcare Realty Trust (HR), Sabra Health Care REIT (SBRA) and EPR Properties (EPR).
View all of NHI's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

National Health Investors' stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.01%), Bank of New York Mellon Corp (2.71%), Northern Trust Corp (2.38%), Charles Schwab Investment Management Inc. (1.17%), Principal Financial Group Inc. (0.94%) and Principal Financial Group Inc. (0.94%). Company insiders that own National Health Investors stock include D Eric Mendelsohn, James R Jobe, Kevin Carlton Pascoe, Robert G Adams, Robert T Webb and W Andrew Adams.
View institutional ownership trends for National Health Investors.

NHI stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Principal Financial Group Inc., Principal Financial Group Inc., Meritage Portfolio Management, Northern Trust Corp, Nuveen Asset Management LLC, Sumitomo Mitsui Trust Holdings Inc., and Los Angeles Capital Management LLC. Company insiders that have sold National Health Investors company stock in the last year include D Eric Mendelsohn, and Kevin Carlton Pascoe.
View insider buying and selling activity for National Health Investors or view top insider-selling stocks.

NHI stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Waterfront Capital Partners LLC, JPMorgan Chase & Co., Bank of New York Mellon Corp, Tudor Investment Corp Et Al, ExodusPoint Capital Management LP, Shilanski & Associates Inc., and Healthcare of Ontario Pension Plan Trust Fund. Company insiders that have bought National Health Investors stock in the last two years include Robert G Adams, Robert T Webb, and W Andrew Adams.
View insider buying and selling activity for National Health Investors or or view top insider-buying stocks.

Shares of NHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NHI stock can currently be purchased for approximately $70.91.

National Health Investors has a market capitalization of $3.17 billion and generates $318.08 million in revenue each year. The real estate investment trust earns $160.46 million in net income (profit) each year or $5.50 on an earnings per share basis.

National Health Investors employs 17 workers across the globe.

The official website for National Health Investors is www.nhireit.com.

National Health Investors is headquartered at 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129.

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust can be reached via phone at 615-890-9100 or via email at [email protected]